Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker JANX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2026 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 23, 2026 | JANX Janux Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 12, 2026 | JANX Janux Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 28, 2026 | JANX Janux Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 26, 2026 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 22, 2026 | JANX Janux Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 22, 2026 | JANX Janux Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2025 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 19, 2025 | JANX Janux Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 7, 2025 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 13, 2025 | JANX Janux Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 27, 2025 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 5, 2024 | JANX Janux Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 2, 2024 | JANX Janux Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 2, 2024 | JANX Janux Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 6, 2024 | JANX Janux Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:52 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances